Results 161 to 170 of about 49,496 (199)

[Drug information: antiparkinson agents. I. Anticholinergic agents].

Sygeplejersken, 1981
Veje Vo
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

[Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].

Eksperimental'naia i klinicheskaia farmakologiia, 2003
A prolonged immunotropic effect of himantane, a new potential antiparkinsonian drug with a multicomponent (including dopaminopositive) mechanism of action, upon the functional activity of splenic B-cells in mice was studied in comparison to the effect of a typical neuroleptic drug haloperidol.
G I, Nezhinskaia, E A, Val'dman, P G, Nazarov, N S, Sapronov   +3 more
openaire   +1 more source

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D₂-Like Receptor and α₁/α₂-Adrenoceptor

, 2002
Adrian Newman‐Tancredi, Didier Cussac, Valérie Audinot, Jean‐Paul Nicolas, Frédéric De Ceuninck, Jean A. Boutin, Mark J. Millan   +6 more
openalex   +1 more source

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

, 2003
Jeffrey N. Joyce, Steve P. Presgraves, Lynn Renish, Sabinne Borwege, Tracy Osredkar, Diane Hagner, Maria Replogle, M. Mateo Paz Soldán, Mark J. Millan   +8 more
openalex   +1 more source

Chapter 8. Information About Antiparkinson Agents For Patients And Families

, 2004

openalex   +1 more source

Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents

, 2014
Hiroyasu Sato, Takeo Kato, Shigeki Arawaka   +2 more
openalex   +1 more source

Withdrawal from long-term use of antiparkinson agents taken with antipsychotic agents

International Clinical Psychopharmacology, 1998
Minako Koga, Sadanobu Ushijima, M. Wakutsu, Hisatsugu Miyata, Kazuhiko Nakayama   +4 more
openaire   +2 more sources

Pharmacokinetic data on antiparkinson and related agents

1992
openaire   +2 more sources

Antiparkinson Agents

2007
openaire   +1 more source

[Antiviral chemotherapeutic agents. XVIII. Adamantane derivatives of amphetamine. Their potential interest as autonomic and antiparkinson agents].

, 1975
C Runti, De Nardo M, S Fabrissin
openalex